Solana-backed biotech firm, iSpecimen, secures a substantial $200 million investment, bolstering the treasury's growth trajectory. Information forthcoming.
In a significant shift for the cryptocurrency market, Solana (SOL) has seen a surge in demand from public companies in 2025. This increased interest is primarily driven by institutional adoption, motivated by staking rewards, treasury diversification, and confidence in Solana’s long-term growth prospects.
Key players such as Upexi, DeFi Development Corporation, SOL Strategies, and Neptune Digital Assets have amassed over 3.5 million SOL tokens, worth roughly $591 million, representing a significant institutional concentration (about 0.65% of circulating supply). These firms are not only holding but actively staking SOL to earn yields around 8%, demonstrating a strategic approach beyond short-term speculation.
Other driving factors include technical upgrades and network improvements enhancing Solana’s scalability and speed, anticipation of regulatory clarity, especially regarding the approval of Solana-related exchange-traded funds (ETFs) by U.S. regulators expected by October 16, 2025, favourable macroeconomic factors, and growing developer activity and ecosystem expansion.
The price impact of this increased demand could push SOL beyond $200. AI-driven models predict SOL could reach $350 by October 2025 and even potentially $520 by year-end, driven by the combination of increased institutional demand, technical upgrades, and ETF approval catalysts.
The strong institutional holding accumulation and staking activity reduce circulating supply pressure, which, coupled with regulatory and technological tailwinds, could create upward price momentum sustaining levels well above $200.
Recently, bio-tech firm iSpecimen announced plans to build a $200 million SOL treasury, signalling increasing market interest in SOL by public firms. This move is part of iSpecimen's digital asset diversification strategy, and it is expected to boost SOL's treasury demand by 20 times.
However, the market cool-off from July profit-taking has affected SOL's recovery. At press time, SOL is valued at $176, and it needs to clear the $180 hurdle to push forward in its potential recovery and soar higher. Bulls have begun to re-enter the SOL market after locking profits, with the number of long positions rebounding from 68% on the 4th August to nearly 72% at press time.
This news underscores the growing appeal of Solana among institutional investors and public companies, and it suggests a promising future for SOL's price performance. The details of iSpecimen's plan and timeline have not been shared yet.
Sources:
[1] The Block [2] CoinDesk [3] Coindesk [4] Bloomberg [5] CNBC
- The surge in demand for Solana (SOL) in 2025 is primarily driven by institutional adoption, with key players such as Upexi, DeFi Development Corporation, SOL Strategies, and Neptune Digital Assets holding over 3.5 million SOL tokens worth $591 million.
- These firms are not only holding but actively staking SOL to earn yields around 8%, demonstrating a strategic approach beyond short-term speculation, as seen in their long-term growth prospects.
- The price impact of this increased demand could push SOL beyond $200, with AI-driven models predicting SOL could reach $350 by October 2025 and even potentially $520 by year-end, driven by the combination of increased institutional demand, technical upgrades, and ETF approval catalysts.
- Recently, bio-tech firm iSpecimen announced plans to build a $200 million SOL treasury, signalling increasing market interest in SOL by public firms and anticipating a boost in SOL's treasury demand by 20 times.
- The market cool-off from July profit-taking has affected SOL's recovery, with SOL currently valued at $176, necessitating a clearance of the $180 hurdle to push forward in its potential recovery and soar higher.
